In this study, we found that the level of FLT3L significantly decreased in peripheral blood in patients with SLE, and human recombinant FLT3L stimulation significantly increased the proportion of CD1c+DCs in lupus PBMCs in vitro. This evidence concerns the gene FLT3LG and systemic lupus erythematosus.